Figure 5 : ImmunoSkew, lymphocyte ratio and treatment outcome.

From: Biopsy variability of lymphocytic infiltration in breast cancer subtypes and the ImmunoSkew score

Figure 5

(A) A negative correlation between ImmunoSkew and lymphocyte ratio. (B) ImmunoSkew further stratifies patients grouped by lymphocyte ratio, particularly in the low lymphocyte ratio group. (C) In HER2 patients treated by both chemotherapy (CT) and radiotherapy (RT), ImmunoSkew identified a subgroup with very poor disease-specific survival.